Inflammatory markers as selection criteria of hepatocellular carcinoma in living-donor liver transplantation

World Journal of Gastroenterology

Volumn 20, Issue 21, 2014, Pages 6594-6601

  Na, Gun Hyung ^a   Kim, Dong Goo ^a   Han, Jae Hyun ^a   Kim, Eun Young ^a   Lee, Soo Ho ^a   Hong, Tae Ho ^a   You, Young Kyoung ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

C reactive protein; Hepatocellular carcinoma; Liver transplantation; Neutrophil lymphocyte ratio; Selection criteria

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ADULT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CRITERION VARIABLE; DISEASE FREE SURVIVAL; FOLLOW UP; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL LYMPHOCYTE RATIO; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PROGNOSIS; AGED; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CYTOLOGY; FEMALE; GENE EXPRESSION REGULATION; LIVER NEOPLASMS; LYMPHOCYTE; METABOLISM; MIDDLE AGED; MORTALITY; NEUTROPHIL; PATIENT SELECTION; PROCEDURES; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; C-REACTIVE PROTEIN; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUTROPHILS; PATIENT SELECTION; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84902082143     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i21.6594     Document Type: Article

References (26)

1. Ishizaki Y, Kawasaki S. The evolution of liver transplantation for hepatocellular carcinoma (past, present, and future). J Gastroenterol 2008; 43: 18-26 [PMID: 18297431 DOI: 10.1007/ s00535-007-2141-x]
2. Moreno P, Jaurrieta E, Figueras J, Benasco C, Rafecas A, Fabregat J, Torras J, Casanovas T, Casais L. Orthotopic liver transplantation: treatment of choice in cirrhotic patients with hepatocellular carcinoma? Transplant Proc 1995; 27: 2296-2298 [PMID: 7652813]
3. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699 [PMID: 8594428 DOI: 10.1056/ NEJM199603143341104]
4. Toso C, Trotter J, Wei A, Bigam DL, Shah S, Lancaster J, Grant DR, Greig PD, Shapiro AM, Kneteman NM. Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma. Liver Transpl 2008; 14: 1107-1115 [PMID: 18668667 DOI: 10.1002/ lt.21484]
5. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394-1403 [PMID: 11391528 DOI: 10.1053/jhep.2001.24563]
6. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-867 [PMID: 12490959 DOI: 10.1038/nature01322]
7. Gomez D, Farid S, Malik HZ, Young AL, Toogood GJ, Lodge JP, Prasad KR. Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg 2008; 32: 1757-1762 [PMID: 18340479 DOI: 10.1007/s00268-008-9552-6]
8. Zheng Z, Zhou L, Gao S, Yang Z, Yao J, Zheng S. Prognostic role of C-reactive protein in hepatocellular carcinoma: a systematic review and meta-analysis. Int J Med Sci 2013; 10: 653-664 [PMID: 23569429 DOI: 10.7150/ijms.6050]
9. Cescon M, Bertuzzo VR, Ercolani G, Ravaioli M, Odaldi F, Pinna AD. Liver transplantation for hepatocellular carcinoma: role of inflammatory and immunological state on recurrence and prognosis. World J Gastroenterol 2013; 19: 9174-9182 [PMID: 24409045 DOI: 10.3748/wjg.v19.i48.9174]
10. Sumie S, Kuromatsu R, Okuda K, Ando E, Takata A, Fukushima N, Watanabe Y, Kojiro M, Sata M. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol 2008; 15: 1375-1382 [PMID: 18324443 DOI: 10.1245/s10434-008-9846-9]
11. Jonas S, Bechstein WO, Steinmüller T, Herrmann M, Radke C, Berg T, Settmacher U, Neuhaus P. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33: 1080-1086 [PMID: 11343235 DOI: 10.1053/ jhep.2001.23561]
12. Pérez-Saborido B, de los Galanes SJ, Menéu-Díaz JC, Romero CJ, Elola-Olaso AM, Suárez YF, Valencia VB, Moreno-González E. Tumor recurrence after liver transplantation for hepatocellular carcinoma: recurrence pathway and prognostic factors. Transplant Proc 2007; 39: 2304-2307 [PMID: 17889172 DOI: 10.1016/j.transproceed.2007.06.059]
13. Figueras J, Ibañez L, Ramos E, Jaurrieta E, Ortiz-de-Urbina J, Pardo F, Mir J, Loinaz C, Herrera L, López-Cillero P, Santoyo J. Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study. Liver Transpl 2001; 7: 877-883 [PMID: 11679986 DOI: 10.1053/jlts.2001.27856]
14. Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 2002; 8: 765-774 [PMID: 12200775 DOI: 10.1053/jlts.2002.34892]
15. Kaido T, Ogawa K, Mori A, Fujimoto Y, Ito T, Tomiyama K, Takada Y, Uemoto S. Usefulness of the Kyoto criteria as expanded selection criteria for liver transplantation for hepatocellular carcinoma. Surgery 2013; 154: 1053-1060 [PMID: 24074704 DOI: 10.1016/j.surg.2013.04.056]
16. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539-545 [PMID: 11229684 DOI: 10.1016/S0140-6736(00)04046-0]
17. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008; 454: 436-444 [PMID: 18650914 DOI: 10.1038/nature07205]
18. Motomura T, Shirabe K, Mano Y, Muto J, Toshima T, Umemoto Y, Fukuhara T, Uchiyama H, Ikegami T, Yoshizumi T, Soejima Y, Maehara Y. Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment. J Hepatol 2013; 58: 58-64 [PMID: 22925812 DOI: 10.1016/j.jhep.2012.08.017]
19. Brodsky SV, Mendelev N, Melamed M, Ramaswamy G. Vascular density and VEGF expression in hepatic lesions. J Gastrointestin Liver Dis 2007; 16: 373-377 [PMID: 18193117]
20. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil- lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005; 91: 181-184 [PMID: 16118772 DOI: 10.1002/jso.20329]
21. Bhatti I, Peacock O, Lloyd G, Larvin M, Hall RI. Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. Am J Surg 2010; 200: 197-203 [PMID: 20122680 DOI: 10.1016/ j.amjsurg.2009.08.041]
22. Gomez D, Morris-Stiff G, Toogood GJ, Lodge JP, Prasad KR. Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma. J Surg Oncol 2008; 97: 513-518 [PMID: 18335453 DOI: 10.1002/jso.21001]
23. Halazun KJ, Hardy MA, Rana AA, Woodland DC, Luyten EJ, Mahadev S, Witkowski P, Siegel AB, Brown RS, Emond JC. Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Ann Surg 2009; 250: 141-151 [PMID: 19561458 DOI: 10.1097/SLA.0b013e3181a77e59]
24. Xiao GQ, Liu C, Liu DL, Yang JY, Yan LN. Neutrophillymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation. World J Gastroenterol 2013; 19: 8398-8407 [PMID: 24363533 DOI: 10.3748/wjg.v19.i45.8398]
25. Hashimoto K, Ikeda Y, Korenaga D, Tanoue K, Hamatake M, Kawasaki K, Yamaoka T, Iwatani Y, Akazawa K, Takenaka K. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer 2005; 103: 1856-1864 [PMID: 15779015 DOI: 10.1002/ cncr.20976]
26. Nagaoka S, Yoshida T, Akiyoshi J, Akiba J, Torimura T, Adachi H, Kurogi J, Tajiri N, Inoue K, Niizeki T, Koga H, Imaizumi T, Kojiro M, Sata M. Serum C-reactive protein levels predict survival in hepatocellular carcinoma. Liver Int 2007; 27: 1091-1097 [PMID: 17845537 DOI: 10.1111/ j.1478-3231.2007.01550.x]